U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07664865) titled 'Harmonization of Teleneuropsychological Assessment in Dementia' on June 11.
Brief Summary: The prevention and management of cognitive decline and dementia represent major healthcare challenges. Neuropsychological assessment is a key component of current diagnostic criteria for Mild Neurocognitive Disorder (mNCD) due to Alzheimer's disease (AD), supporting both diagnosis and patient follow-up. It enables the evaluation of cognitive domains, monitoring of disease progression, and assessment of treatment effects.
Digital tools offer standardized, objective, and scalable methods for cognitive evaluation. The growth of telemedicine and ...